IP Library Granted Patent US 8,741,567
Granted Patent B2
US 8,741,567 · App. 13/095,505 · Granted Jun 3, 2014

Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmC)

Inventors: Chuan He (Chicago, IL); Chunxiao Song (Chicago, IL)
Assignee: The University of Chicago
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,567
App. No.
13/095,505
Granted
Jun 3, 2014
Kind
B2
Abstract

The present invention relates generally to the field of molecular biology. More particularly, it concerns methods and compositions for detecting, evaluating, and/or mapping 5-hydroxymethyl-modified cytosine bases within a nucleic acid molecule.

Claims (28)

1. A method for distinguishing by glycosylation with a modified glucose molecule 5-hydroxymethylcytosine from 5-methylcytosine in a nucleic acid molecule of an isolated sample comprising:

placing in a reaction mixture the nucleic acid molecule with β-glucosyltransferase and a synthetically modified uridine diphosphoglucose (UDP-Glu) molecule comprising a modification moiety to glycosylate 5-hydroxymethyl-cytosines in the nucleic acid molecule with a modified glucose molecule, wherein the modification moiety comprises a linker, a detectable moiety, an isolation tag, a blocking moiety, or a functional moiety.

2. The method of claim 1 , wherein the nucleic acid molecule is a nucleic acid molecule further purified from the isolated sample.

3. The method of claim 2 , wherein the purified nucleic acid molecule is located on an array.

4. The method of claim 1 , wherein the modification moiety comprises a linker.

5. The method of claim 4 , wherein the modification moiety comprises an azide linker.

6. The method of claim 4 , wherein the modification moiety comprises a thiol linker.

7. The method of claim 1 , further comprising isolating the nucleic acid molecule from a cell of the isolated sample prior to glycosylation of the nucleic acid molecule.

8. The method of claim 1 , further comprising reacting the modified glucose in the glycosylated nucleic acid molecule with a detectable or functional moiety.

9. The method of claim 8 , wherein the glucose is modified with an azide or thiol linker.

10. The method of claim 1 , further comprising placing the glycosylated nucleic acid molecule in a reaction mixture with an enzyme that is not β-glucosyltransferase.

11. The method of claim 10 , wherein the enzyme is a restriction enzyme or a polymerase.

12. The method of claim 11 , wherein the restriction enzyme is methylation-insensitive.

13. The method of claim 11 , wherein the enzyme is polymerase.

14. The method of claim 13 , wherein the glycosylated nucleic acid molecule is placed in a reaction mixture with polymerase, at least one primer, and one or more nucleotides under conditions to allow polymerization of a transcript of the glycosylated nucleic acid molecule.

15. The method of claim 14 , further comprising sequencing the polymerized transcript of the glycosylated nucleic acid molecule.

16. The method of claim 1 , further comprising isolating the glycosylated nucleic acid molecule from the reaction mixture.

17. A method for mapping by glycosylation with a modified glucose molecule 5-hydroxymethylcytosine in a nucleic acid molecule of an isolated sample comprising:

placing in a reaction mixture the nucleic acid molecule with β-glucosyltransferase and a synthetically modified uridine diphosphoglucose (UDP-Glu) molecule comprising a modification moiety to glycosylate 5-hydroxymethylcytosines in the nucleic acid molecule with the modified Glu molecule, wherein the modification moiety comprises a linker, a detectable moiety, an isolation tag, a blocking moiety, or a functional moiety; and

mapping the glycosylated 5-hydroxymethylcytosines in the glycosylated nucleic acid molecule by sequencing the glycosylated nucleic acid molecule.

18. The method of claim 17 , wherein sequencing further comprises sequencing a control nucleic acid molecule.

19. The method of claim 14 , wherein sequencing further comprises a primer extension assay.

20. The method of claim 17 , further comprising placing the glycosylated nucleic acid molecule in a reaction mixture with an enzyme that is not β-glucosyltransferase before sequencing the glycosylated nucleic acid molecule.

21. The method of claim 20 , wherein the enzyme is a restriction enzyme or a polymerase.

22. The method of claim 21 , wherein the restriction enzyme is methylation-insensitive.

23. The method of claim 21 , wherein the enzyme is polymerase.

24. The method of claim 23 , wherein the glycosylated nucleic acid molecule is placed in a reaction mixture with polymerase, at least one primer, and one or more nucleotides under conditions to allow polymerization of a transcript of the glycosylated nucleic acid molecule.

25. The method of claim 24 , further comprising sequencing the polymerized transcript of the glycosylated nucleic acid molecule.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 14, 2012
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028372/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2011
From: HE, CHUAN; ZHANG, LIANG; SONG, CHUNXIAO
To: THE UNIVERSITY OF CHICAGO
Reel/Frame 026613/0106 →
Continuity (3)
Continuation PCTUS2011031370 · Apr 6, 2011
Provisional Application 61321198 · Apr 6, 2010
Related Publication 20110301045A1 · Dec 8, 2011